The Endocrine Society
now issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of disorders involving the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study involved nearly 800 elderly men with low testosterone and symptoms related to this condition, such anti aging supplements hgh; see
, as physical and sexual dysfunction. Since the men's heart health was monitored, the research is expected to shed more light on the safety of testosterone treatment.
Studies have shown that testosterone deficiency is associated with a number of significant health problems such as metabolic syndrome, obesity, diabetes, and bone fractures Men who meet medical standards for treatment
should get therapy. Actually, your testosterone levels have likely been slowly declining for some time, a decline that typically begins around age 30.
And many women have a knee jerk suspicion that any hormone treatment can raise their risk of breast cancer. However, clinical studies demonstrate that testosterone not only doesn't raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser thinks this will probably remain the status quo for a little while, given the prohibitive cost of conducting the long term safety studies needed to acquire completer FDA acceptance.